Couldn't agree more. Anything one has is always different/better than the next person. Hate to break it to you, but Missling is like any other bioech CEO: trying to keep the company afloat while taking his "shot in the dark."
I agree totally--i have lost so much $$ over the years in small biotechs and they are always the same. They don't have enough $$ for trials, they are waiting on the elusive "magic" data, etc. We have to question Missling and stay on him--hold the company accountable. Cannot just blindly follow any of these CEO's.
No date was ever set on PK release. Company and FDA may have data right now and are using it to guide set up of phase3 trial . All bio's have dates slip especially one with multiple irons in the fire.
re:" In biotechs - certain steps such as pk/pd data have expected timelines - and if companies start slipping them - assume that something is wrong "
Nothing is wrong. Posters complaining that they want pk/pd data - do they even know what thay are asking for? Below is an example of pk/pd data - there will be hundreds of pages like that for each patient. It's meaningless and irrelevant to an investor.